|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/337 | |
| A61P 35/00 |
| (11) | Patento numeris | 2421562 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10766565.5 |
| Europos patento paraiškos padavimo data | 2010-04-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-02-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-03-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CA2010/000618 |
| Data | 2010-04-20 |
| (87) | Numeris | WO 2010/121379 |
| Data | 2010-10-28 |
| (30) | Numeris | Data | Šalis |
| 171040 P | 2009-04-20 | US |
| (72) |
CASTAIGNE, Jean-Paul, CA
DEMEULE, Michel, CA
LAWRENCE, Betty, CA
|
| (73) |
Angiochem Inc.,
4150 rue Ste. Catherine Ouest, Suite 490, Westmount, QC H3Z 2Y5,
CA
|
| (54) | TREATMENT OF OVARIAN CANCER USING AN ANTICANCER AGENT CONJUGATED TO AN ANGIOPEP-2 ANALOG |
| TREATMENT OF OVARIAN CANCER USING AN ANTICANCER AGENT CONJUGATED TO AN ANGIOPEP-2 ANALOG |